BIOMAT Database Logo BIOMAT Database Logo

Equivalence of lanoxin tablets. 1976

S M Dobbs, and E M Rodgers, and B G Woodcock

UI MeSH Term Description Entries
D008297 Male Males
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

S M Dobbs, and E M Rodgers, and B G Woodcock
Transition from Lanoxin capsules to Lanoxin tablets in the debilitated elderly.
April 1990, DICP : the annals of pharmacotherapy,
S M Dobbs, and E M Rodgers, and B G Woodcock
The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
April 1977, British journal of clinical pharmacology,
S M Dobbs, and E M Rodgers, and B G Woodcock
Equivalence of levothyroxine tablets.
April 1983, Drug intelligence & clinical pharmacy,
S M Dobbs, and E M Rodgers, and B G Woodcock
The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
December 1978, European journal of clinical pharmacology,
S M Dobbs, and E M Rodgers, and B G Woodcock
[Lanoxin].
November 1972, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
S M Dobbs, and E M Rodgers, and B G Woodcock
Non-equivalence of digoxin tablets.
January 1974, Annals of clinical research,
S M Dobbs, and E M Rodgers, and B G Woodcock
[Clinical equivalence between digoxin tablets?].
February 1973, Lakartidningen,
S M Dobbs, and E M Rodgers, and B G Woodcock
Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets.
January 1974, British heart journal,
S M Dobbs, and E M Rodgers, and B G Woodcock
Physicochemical equivalence of chloroquine phosphate tablets.
December 2004, African journal of medicine and medical sciences,
S M Dobbs, and E M Rodgers, and B G Woodcock
Letter: Therapeutic non-equivalence of digoxin tablets.
April 1974, British medical journal,
Copied contents to your clipboard!